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Investigating the Glycating 
Effects of Glucose, Glyoxal and 
Methylglyoxal on Human Sperm
Clare Nevin1, Lauren McNeil1, Nessar Ahmed1, Chris Murgatroyd1, Daniel Brison2 & Michael 
Carroll1
Glycation is the non-enzymatic reaction between reducing sugars, such as glucose, and proteins, 
lipids or nucleic acids, producing Advanced Glycation End (AGE) products. AGEs, produced during 
natural senescence as well as through lifestyle factors such as diet and smoking, are key pathogenic 
compounds in the initiation and progression of diabetes. Importantly, many of these factors and 
conditions also have influence on male fertility, affecting sperm count and semen quality, contributing 
to the decreasing trend in male fertility. This study investigated the impact of AGEs on sperm damage. 
In vitro sperm glycation assays were used to determine the levels and localization of the potent AGE 
compound, carboxymethyl-lysine (CML) in response to treatment with the glycating compounds 
glucose, glyoxal and methylglyoxal. Sperm function assays were then used to assess the effects of 
glycation on motility and hyaluronan binding, and levels of oxidative DNA damage were analyzed 
through measurement of the marker, 8-oxoguanine. Results showed that glyoxal, but not glucose 
or methylglyoxal, induced significant increases in CML levels on sperm and this correlated with an 
increase in 8-oxoguanine. Immunocytochemistry revealed that AGEs were located on all parts of the 
sperm cell and most prominently on the head region. Sperm motility and hyaluronidase activity were 
not adversely affected by glycation. Together, the observed detrimental effects of the increased levels 
of AGE on DNA integrity, without an effect on motility and hyaluronidase activity, suggest that sperm 
may retain some fertilizing capacity under these adverse conditions.
Many studies over the past few decades have indicated that semen quality has declined1, possibly owing to mod-
ern lifestyle factors, such as diet, smoking tobacco and drinking alcohol, and the rise in health conditions such 
as obesity and diabetes2. A recent study demonstrated that lifestyle factors, diet and age were positively asso-
ciated with increased levels of Advanced Glycation End (AGE) Products, which are detrimental to health and 
reproduction3.
AGEs are a heterogeneous group of compounds that form from the non-enzymatic reaction of a carbonyl 
group of a reducing sugar with the free amino-group of proteins4. This process, known as the Maillard reac-
tion5, can occur endogenously, where biomolecules such as proteins, lipids and nucleic acids become covalently 
modified during the process of AGE formation6. AGE-modified proteins cause damage to cells and tissues by 
crosslinking other proteins, such as extracellular matrix proteins, and activating cellular inflammatory response 
pathways through interaction with the receptor for AGE, RAGE. The level of AGEs is further increased by the 
action of highly reactive AGE intermediates, including methylglyoxal (MG) and glyoxal (GO), which are formed 
when AGEs degrade and through Schiff base fragmentation, as summarised in Fig. 1. These intermediates then 
proceed to form additional AGEs at a faster rate than reducing sugars7.
AGE formation is accelerated under conditions including hyperglycaemia, insulin resistance, dyslipidemia 
and oxidative stress8–10 leading to the presence of higher levels in chronic age-related diseases, including cardi-
ovascular disease, diabetic nephropathy, nerve damage, retinopathy and atherosclerosis11–15. Increased levels of 
AGEs within tissues are also associated with consumption of AGE-rich foods, particularly animal-based products 
high in fat and protein16,17, and other life-style factors such as smoking tobacco18.
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Interestingly, many of the above conditions including diabetes and obesity, and lifestyle exposures such as 
smoking have also been linked to declines in semen quality and fertility1,18–21. Furthermore, the damaging impact 
of glycation on testicular function has been reported in numerous studies of animal models showing links with 
Leydig cell function and erectile dysfunction22–24. AGEs have been located in the human male reproductive tract, 
on sperm cells and in soluble form in the seminal plasma25,26 suggesting that they may form modifications on 
functionally important sperm proteins or induce DNA adducts.
Glycation and the formation of AGE can generate reactive oxygen species (ROS). This can happen through 
AGE-RAGE activation of the NFkB (nuclear factor kappa-light-chain-enhancer of activated B cells) inflamma-
tory pathway leading to subsequent NADPH and ROS production27. The presence of AGE therefore has the 
potential to cause particular damage to sperm due to their high vulnerability to oxidative stress. This is a result of 
the high level of polyunsaturated fatty acids in the sperm membrane, which undergo lipid peroxidation when lev-
els of ROS exceed the antioxidant capacity of the seminal plasma, leading to cell membrane damage and impaired 
motility and morphology28,29. Furthermore, elevated ROS levels cause sperm DNA fragmentation, a marker of 
infertility, which is not detected through conventional semen analysis30.
AGE and RAGE have previously been detected on sperm and in the male reproductive tract, suggesting that 
this signalling pathway may have a role in sperm damage. Other studies have demonstrated a role for AGEs 
in diabetes-related sperm dysfunction31. For example, within the seminal plasma of diabetics compared to 
non-diabetics higher levels of total AGEs were found together with increased lipid peroxidation (malondialde-
hyde) and reduced total antioxidant capacity32. Carboxymethyl-lysine (CML), a common AGE, has been located 
throughout the seminiferous epithelium and on sperm cells of healthy and diabetic men, with the acrosomal 
cap being more prominently stained for CML in diabetics25. RAGE is also found throughout the testis and the 
epididymis, as well as on the head region of sperm cells at greater levels in diabetics than non-diabetics30 and this 
directly correlated with sperm DNA fragmentation31. The occurrence of AGE and RAGE in healthy males shows 
that these compounds have some role in sperm function, and their elevated levels in diabetics suggest that they 
could play a pathological role in these men’s infertility.
The role of AGE in sperm function has not been explored in depth. This study is the first to investigate the in 
vitro effects of glycation on human sperm function, through the assessment of several sperm parameters, includ-
ing DNA integrity. An in vitro assay system was used to delineate a mechanistic link between AGE formation and 
Figure 1. Glycation through the Maillard reaction. AGEs are formed through the Maillard reaction in which 
the carbonyl group of a reducing sugar, such as glucose, reacts with the amine group of a protein side chain 
residue, such as lysine. Initially a reversible Schiff base adduct is formed, which then undergoes a series of 
rearrangements to form an Amadori product. Further glycation and oxidation reactions lead to the formation 
of a primary AGE Nε-(carboxymethyl)lysine (CML). Fragmentation of the Schiff base generates the AGE 
intermediates methylglyoxal (MG) and glyoxal (GO). These reactive carbonyl compounds also react with 
biomolecules to produce AGEs.
www.nature.com/scientificreports/
3SCiENTiFiC REPORts |  (2018) 8:9002  | DOI:10.1038/s41598-018-27108-7
sperm function and DNA damage. The data presented may pave the way for further in vivo studies concerning 
glycation-induced sperm damage and male infertility.
Results
Long-term in vitro glycation. Vitality and motility of sperm after incubation with glycating agents. Sperm 
incubated with glucose at 30 and 50 mM retained greater sperm vitality after 6 days, at 43.4% (p < 0.001) and 
51.4% (p < 0.001) respectively, compared with SPM (Sperm Preparation Media) samples at 10% vitality (Fig. 2A).
Sperm vitality was measured using the eosin-nigrosin stain after treatment with glucose (30 and 50 mM), MG 
(50 µM) and GO (50 µM) for 6 days. Sperm vitality decreased in all treatment groups at the end of the incubation 
period but the presence of glucose maintained vitality at a significantly higher level than Sperm Preparation 
Media, SPM (***p < 0.001). The presence of MG and GO also showed significantly higher vitality than SPM 
(*p < 0.05) (Fig. 2B). Total progressive sperm motility significantly decreased over time for all treatment groups 
(**p < 0.01) (Fig. 2C). However, there was no significant difference between sperm treated with glycating com-
pounds and SPM, nor between mannitol-treated sperm and glucose-treated sperm.
Figure 2. Effect of glycating compounds on sperm vitality and motility. (A) The percentage of live sperm 
following incubation with glucose (Glc) (n = 3) (30 mM and 50 mM), (B) methylglyoxal, MG (n = 3) (50 µM) 
and glyoxal, GO (n = 3) (50 µM) for 6 days, measured using the eosin-nigrosin stain. Sperm vitality decreased 
in all treatment groups at the end of the incubation period, but the presence of glucose maintained vitality at 
a significantly higher level than Sperm Preparation Media, SPM (***p < 0.001). The presence of MG and GO 
also showed significantly higher vitality than SPM (*p < 0.05). (C) Sperm progressive motility had significantly 
decreased after 72 hours for all treatment groups (n = 3) (**p < 0.01) but did not significantly differ between the 
groups. Error bars represent mean +/− SD.
www.nature.com/scientificreports/
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Measurement of AGE levels. Incubation of sperm with glucose and AGE intermediates GO and MG was carried 
out to examine the role of glycation on sperm function and whether AGE were formed in their presence. The level 
of CML, a prevalent AGE that has been previously detected on sperm cells25, was measured and found to be sig-
nificantly elevated in response to GO (Fig. 3A). Sperm incubated with MG demonstrated no significant difference 
in the levels of CML compared to sperm treated with SPM or glucose. Glucose (30 mM and 50 mM) did not cause 
any change in CML compared to SPM. (Fig. 3B).
Immunolocalisation of AGE and CML. To infer which sperm functions may be affected by glycation, the loca-
tion and distribution of AGE on glycated sperm was determined by immunocytochemistry. CML-positive flu-
orescence could be seen strongly along the tail and midpiece regions of sperm treated with MG (Fig. 4Aii) and 
GO (Fig. 4Aiii), but less so with SPM (Fig. 4Ai). The Corrected Total Cell Fluorescence (CTCF) showed that in 
the head region, GO-treated sperm had significantly (*p < 0.05) higher CML fluorescence than SPM and MG 
(Fig. 4B). This fluorescence appeared strongly at the anterior part of the sperm head, encompassing the acroso-
mal region Fig. 4Aiii, arrow) (n = 3). Immunolocalisation of general AGE on sperm after glycation with GO, MG 
revealed some staining all treatment groups (Fig. 4C), with both GO and SPM showing significantly higher head 
fluorescence than MG after CTCF (Fig. 4D).
Glycating compounds and oxidative stress. The present study has established AGE formation on sperm upon 
treatment with glycating agents in vitro. The effect of this observed AGE formation on ROS production and sub-
sequent oxidative damage to sperm was then investigated.
Intracellular ROS were measured in sperm after the long-term (6-day) glycation incubation period. Sperm 
were incubated with 30 mM glucose only, as previous treatments with both 30 mM and 50 mM showed no sig-
nificant difference in AGE formation. The results showed no significant differences in ROS levels between sperm 
incubated with glucose or the intermediate glycating agents, GO and MG (Fig. 5A). Although differences in 
ROS levels were not detected, when an end-product of oxidative DNA damage, 8-oxoguanine, was measured, 
a significantly higher level was found in sperm incubated with GO in comparison to SPM (**p < 0.01) glucose 
(**p < 0.01) and MG (*p < 0.05) (Fig. 5B).
Short term in vitro glycation. As AGE intermediates react rapidly and form more readily than reduc-
ing sugars such as glucose, CML formation was measured over a four hour time period, rather than 6 days as 
in previous experiments. Exposure to GO caused rapid generation of CML after only two hours in culture, 
which increased further at four hours (Fig. 6A). This was significantly greater than CML levels from SPM- and 
MG-treated cells (p < 0.001). Importantly, the rapid increase in CML levels did not correlate with a change in 
sperm progressive motility (Fig. 6B).
As sperm interact with a number of ligands during fertilization, the effect of the observed CML formation on 
Spam1, an important membrane protein in sperm-oocyte interaction, were investigated33,34. Sperm hyaluronidase 
activity showed no significant change following 4 hours of in vitro glycation with MG or GO. (Fig. 6C).
Discussion
Glycation is the spontaneous non-enzymatic reaction of a carbonyl group of a reducing sugar with a protein 
amine group, which through multiple successive reactions forms covalent irreversible AGEs.
Figure 3. Carboxymethyl lysine formation in response to glycating agents. (A) Incubation of sperm with 
GO (50 µM) (n = 5) for 6 days resulted in a significant increase in the level (mean MFI +/− SD) of CML in 
comparison to SPM (n = 5) (p < 0.01) and MG (n = 5) (p < 0.05). (B) Incubation of sperm with 30 mM glucose 
(Glc) (n = 3) or 50 mM glucose (n = 3) had no effect on CML levels in comparison to SPM (n = 3). Error bars 
represent mean +/− SD.
www.nature.com/scientificreports/
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AGEs and the reactive intermediates such as MG can covalently adduct to proteins, which may induce struc-
tural and functional changes that could alter molecular conformation and enzymatic activity. AGEs can also 
increase inflammation and oxidative stress by forming ROS35 through interactions with the RAGE. MG also 
disrupts the electron transport chain in mitochondria36.
Figure 4. Immunolocalisation of CML and AGE on sperm. (A) Immunocytochemical staining of CML on 
SPM (i), MG (ii) and GO (iii) sperm revealed strong positive staining (green) on the tail of MG and GO sperm, 
and uniquely on the head region of sperm incubated with GO (arrow) (n = 3). Negative control showed no 
CML staining (iv). (B) Mean (+/− SD) corrected total cell fluorescence (CTCF) was calculated from 10 cells of 
different experimental replicates and showed CML to be significantly higher in the head region of GO sperm 
(p < 0.05). (C and D) General AGE staining (green) indicated the presence of AGEs on all treatment groups, 
with both GO (iii) and SPM (i) showing significantly higher head fluorescence than MG (ii) (arrow) (p < 0.01, 
p < 0.05, respectively) (n = 3). Magnification was at 100× oil immersion. Nuclear staining is shown in blue 
(DAPI).
Figure 5. Intracellular ROS production and oxidative DNA damage. The effects of sugars and intermediate 
compounds on intracellular ROS levels in sperm. (A) Relative ROS levels in sperm treated with SPM (n = 3), 
glucose (Glc, 30 mM) (n = 3), MG (50 μM) (n = 3) or GO (50 μM) (n = 3) for 6 days. ROS is shown as mean 
fluorescence intensity (MFI) +/− SD of flow cytometry detection. One-way ANOVA analysis revealed no 
difference in ROS levels between any of the treatment groups. (B) 8-oxoguanine levels were measured in 
sperm treated with SPM (n = 3), glucose (Glc, 30 mM) (n = 3), MG (50 μM) (n = 3) and GO (50 μM) (n = 3). 
8-oxoguanine levels are shown as MFI of flow cytometry detection. GO treatment caused significantly more 
8-oxoguanine generation in comparison to MG (*p < 0.05), glucose (*p < 0.01) and SPM (*p < 0.01). Error bars 
represent mean +/− SD.
www.nature.com/scientificreports/
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As AGE have been located on sperm cells and in the male reproductive tract25, this study sought to use an in 
vitro experimental model to investigate possible effects of these compounds on sperm function. The reducing 
sugar glucose was used as a physiologically relevant inducer of AGE formation, and the reactive AGE interme-
diates MG and GO, were used to illustrate the rapid glycating effect of these compounds. The main findings of 
this study were that CML, a common and potent AGE was rapidly formed on sperm when incubated with GO. 
Glycated sperm experienced higher levels of 8-oxoguanine formation, indicating a role for AGE-mediated DNA 
damage.
Over a 6-day period in culture, CML levels did not increase in sperm incubated with glucose. This low reactiv-
ity of glucose is rational given its role as the most abundant sugar within biological systems; high glucose reactiv-
ity would cause inevitable damage to biomolecules. This result was unsurprising as many studies investigating the 
chemical processes of glucose-mediated glycation have shown that this can take from 1 to 4 weeks, often as long 
as the turnover time of the proteins in vivo37–39. Furthermore, a recent study demonstrated that sperm parameters, 
such as motility and viability were unaffected by exposure to high levels of glucose in vitro40.
As sperm are haploid, non-dividing cells, they can only be maintained in culture for limited periods (<1 week), 
and as glycation is directly dependent on glucose concentration and time39, glucose was used at concentrations 
higher than normal physiological levels. Under healthy conditions, glucose levels are between 4–6 mM in blood 
and 1 mM in seminal plasma, while hyperglycaemic type 2 diabetics experience blood glucose levels of 11 mM up 
Figure 6. Short term glycation of sperm by GO. (A) CML levels (MFI +/− SD) in sperm treated with SPM, 
MG and GO (n = 3). Sperm incubated with GO showed an increase in CML at 2 hours (BA) and 4 hours (BB), 
both significantly higher than MG and GO at these time points (AA and AB). ****p < 0.0001, **p < 0.01. Key 
applies to (A), (B) and (C). (B) Sperm progressive motility (mean +/− SD) during glycation with SPM, MG 
and GO (n = 3). Two-way ANOVA showed no significant difference in progressive motility over 4 hours and 
between any treatment group. (C) HA binding of sperm incubated with MG and GO (n = 3). No difference was 
seen in hyaluronan binding capacity at 2 or 4 hours. Sperm maintained a high level of binding throughout. Error 
bars represent mean +/− SD.
www.nature.com/scientificreports/
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to and sometimes above 30 mM. In this glycation assay, neither 30 mM nor 50 mM glucose increased CML levels 
after 6 days. It is also possible that the lack of CML formation in response to glucose was due to sperm metab-
olising the glucose in solution, causing a decrease in concentration to levels insufficient for glycation. In some 
fertility clinics, sperm are maintained in culture media such as SPM for a number of hours. This medium is opti-
mised for sperm function and contains glucose at approximate levels of less than 1 mM (http://www.origio.com), 
which the results of this study suggest would be insufficient for glycation-mediated damage to occur to sperm41.
The AGE intermediates GO and MG are reactive carbonyl compounds (RCCs). They are formed during the 
Maillard reaction but also from the oxidation of AGEs7. RCCs rapidly form Schiff bases with amino acids, hence 
their greater reactivity than glucose, and eventually form imidazolone adducts with molecules, which can cause 
cytotoxicity to different cell types42. This in vitro study showed that exposing sperm to GO for as little as 2 hours 
caused a significant increase in CML levels compared with SPM and MG.
Although the concentrations of MG and GO used here were higher than normal physiological levels which 
are approximated to be 100–120 nM in blood plasma7, high levels were used to illustrate the potential effects of 
these compounds at a measurable level, and in line with, if not lower than, those used in other in vitro cell assays43.
Immunocytochemical staining of glycated sperm was carried out in order to demonstrate the distribution of 
general AGEs and the more specific AGE, CML on the sperm cells after exposure to glycating compounds in vitro. 
The staining of CML along the entire length of the cell, including head, midpiece and tail is in accordance with 
the staining pattern found by Mallidis et al.25. They also described high immunoreactivity to CML on the head 
acrosomal cap region in diabetic men compared to non-diabetics where immunoreactivity was low. This is simi-
lar to the higher level of CML staining found here on sperm from healthy men glycated with GO compared with 
SPM when quantified using corrected total cell fluorescence (Fig. 4A,B). Although caution must be taken when 
extrapolating in vitro data with in vivo studies, the use of this in vitro assay may be a good model for mimicking 
the diabetic environment.
To explore the immunocytochemical staining of general AGE compounds on sperm, an anti-AGE antibody, 
targeting general AGE compounds was used. This revealed no significant difference between GO treated and con-
trol (SPM) sperm (Fig. 4C,D), in contrast to the CML-specific staining (Fig. 4A,B), suggesting that the changes 
we see are more specific to CML than all AGEs in general. It is interesting to note that in MG treated sperm there 
was actually a decrease in general AGE labelling compared to control in contrast to the CML data. Importantly, 
as AGEs are heterogeneous, the general anti-AGE antibody used can react with a wide number of glycated com-
pounds and the degree of labelling might differ as a result of the affinity of the anti-AGE antibody. Thus, as CML 
is the physiological AGE associated with AGE-related pathologies it was important that we focused more on the 
effects of this AGE compound.
GO and MG have been shown to cause rapid generation of CML on proteins such as BSA and lysozyme in vitro37,42. 
Therefore, the CML production seen in the first four hours on sperm is possibly occurring on structurally availa-
ble proteins such as receptors on the sperm membrane, while later CML generation could be occurring as a result 
of adduct formation on intracellular proteins and DNA. Although AGE formation was originally thought to only 
affect stable extracellular proteins, such as collagen, it is now clear that glycation adducts can quickly form on 
intracellular proteins such as actin44 and on DNA45.
Cell-based in vitro glycation assays have previously shown that cell receptors such as the platelet derived 
growth factor receptor are vulnerable to glycation39. Critically, modification of these receptors by AGE intermedi-
ates can alter their function, as was shown through inhibited epidermal growth factor receptor signalling46. Sperm 
participate in a number of receptor-ligand interactions to which glycation could be detrimental, such as for the 
hyaluronidase activity of Spam1, which is responsible for degradation of HA oligosaccharide chains found in the 
cumulus layer of granulosa cells surrounding the oocyte34. Spam1 is located on the acrosomal membrane where 
a high level of CML immunoreactivity was observed in this study, and as this protein contains a number of lysine 
and arginine residues, this enzyme could be affected by glycation. Therefore, the function of sperm hyaluronidase 
binding was investigated in response to glycation.
Sperm binding to HA was not affected following short-term glycation. As the hyaluronan binding assay 
requires motile sperm in order to distinguish between sperm that are bound (hyaluronidase active) and 
unbound (hyaluronidase inactive), the experiment could not be carried out at 6 days when sperm motility is 
compromised47.
The oxidized guanine nucleotide, 8-oxoguanine, is the most common DNA lesion that occurs as a result 
of oxidative damage by ROS. The lesion proceeds to destabilise the DNA structure through altered oxoGC 
pairing. In the present study, 8-oxoguanine was found to be increased in sperm with elevated CML levels, sug-
gesting that oxidative DNA damage occurs alongside AGE formation. AGE-related ROS generation can hap-
pen in a number of ways. Firstly, AGE intermediates can cause ROS generation during the glycation process, 
as well as independently of AGE formation44. Therefore, the process of CML formation seen here is likely to 
be triggering ROS formation, such as has been demonstrated in endothelial cells, and which is inhibited in the 
presence of radical-scavenging enzymes45. Another major source of ROS arises through AGE binding to their 
receptor, RAGE, on the cell membrane. AGE-RAGE binding is important in AGE pathology in various tissues. 
Furthermore, RAGE has also been located on the sperm membrane and its expression positively correlates with 
DNA damage25,26. Importantly, both of these parameters are elevated in the sperm of diabetic men31. Although 
mature sperm are transcriptionally quiescent, which may suggest a limited capacity for NFκB cell signalling, 
immature sperm in the seminiferous tubules still have active gene expression and would be vulnerable to ROS 
generation through this pathway.
Despite glycation being associated with oxidative DNA damage, ROS levels were not different between sperm 
incubated with the different glycating compounds. This may be due to the extensive experimental time period, 
in which case ROS generation would be at a maximum across all samples as cell death began to occur. This effect 
would have been increased as a result of the absence of seminal plasma, the source of antioxidants and radical 
www.nature.com/scientificreports/
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scavenging enzymes important for sperm protection48,49. Additionally, as ROS are unstable, a more sensitive assay 
may be required to detect low levels of ROS.
Sperm are particularly susceptible to DNA damage, which occurs primarily due to oxidative stress in these 
cells49 as they lack the repair mechanisms present in somatic cells. Furthermore, the glyoxalase pathway, which 
detoxifies AGE intermediates through the action of Glyoxalase 150 has not been identified in sperm. The impli-
cations of such damage for sperm in vivo are reduced cell function, ultimately leading to poorer fertilisation 
capacity. 8-oxoguanine levels have also been linked to lower pregnancy rates independent of semen quality51,52. 
This study found no significant change in the motility of sperm treated with GO where oxidative DNA damage 
was highest. However, oxidative DNA damage can occur in normal and abnormal sperm, and as ART treatment 
does not take into account the analysis of DNA damage routinely, this may have consequences for embryonic 
development and offspring health53,54.
Conclusion
The present study shows that AGE compounds are formed on human sperm upon exposure to the reactive GO 
in vitro, leading to a significant increase in the oxidative DNA adduct, 8-oxoguanine. Importantly, there was no 
significant impacts on sperm motility or sperm hyaluronan binding after exposure to the glucose or the reactive 
AGE intermediates.
In summary, this study demonstrates that glycation induces sperm DNA damage without evident differences 
in sperm function when tested for changes in standard semen parameters.
Materials and Methods
Human Biological Material. Human Biological Material. Human semen samples were obtained from 
seven healthy normospermic, non-diabetic, consenting donors (aged 19–35 years). All donors signed informed 
consent and samples were processed in accordance with faculty ethical approval at Manchester Metropolitan 
University. Semen samples were obtained via masturbation after 3–5 days of sexual abstinence for provision of 
quality samples, in accordance with recommendations by the World Health Organization (WHO)55. This mini-
mised variation in sample quality and sperm DNA integrity that occurs with length of abstinence56.
Semen samples were allowed time for liquefaction to complete before further analysis and preparation. 
Density gradient centrifugation was used to isolate sperm from seminal plasma. Briefly, 1 ml of semen was layered 
on top of a gradient of 55% and 80% SupraSpermTM media (Origio, Denmark) and centrifuged at 300 g for 20 min-
utes. The supernatant was removed and discarded and the sperm pellet was washed twice in Sperm Preparation 
MediaTM (SPM, Origio, Denmark), by centrifugation at 300 g for 5 minutes. The cells were then resuspended in 
1 ml SPM. All downstream experiments were carried out with washed, semen-free sperm.
In vitro glycation assays. To establish the effect glycating agents have on sperm vitality and motility in an in vitro 
system, sperm were incubated with various glycating compounds over long-term (6 days) and a short-term incu-
bation periods (0, 2 and 4 hours). 3 donors were used for the long-term experiments, and samples from another 
set of 3 donors were used for the short-term experiments. Long-term experiments were carried out to show the 
glycating effects of glucose, which has low reactivity relative to glucose-6-phosphate57 or other reducing sugars 
such as D-ribose58. A period of 6 days was chosen as glucose has previously shown no glycating effects on cultured 
cells over 2 days58. Mannitol - a non-reducing sugar - was included in initial experiments to control for osmotic 
effects of glucose59. The highly reactive AGE intermediates, MG and GO, were used as an accelerated model for the 
glycation of sperm. Cellular levels of these compounds are predicted to be approximately 1–5 µM and 0.1–1 µM, 
respectively60. However, physiological levels of MG have been reported to be in the nM61, µM62 and mM63  
range. The concentrations implemented in this study were higher in order to simulate a disease environment and 
were in line with those used in other studies39.
For the long-term in vitro glycation experiments, motile sperm separated by density gradient centrifuga-
tion were pelleted and resuspended at a concentration of 20 × 106/ml in solutions of SPM containing D-glucose 
(30 mM or 50 mM), Mannitol (30 mM). These concentrations were used to mimic diabetic hyperglycemia and to 
asses sperm response to massive doses of glucose40. Sperm were also exposed to methylglyoxal (MG) (50 μM), 
glyoxal (GO) (50 μM) or SPM alone. Sperm were incubated at 34 °C on a rotator for 6 days before analysis of 
CML formation, ROS levels and oxidative DNA damage. Incubations were carried out at a temperature of 34 °C 
in order to best represent the scrotal environment of normospermic men64. Sperm vitality was assessed after the 
long-term incubation experiments using the eosin-nigrosin stain as outlined above and motility was measured 
using the CASA65.
For the short-term in vitro glycation experiments, sperm at a concentration of 20 × 106/ml were treated with 
solutions of SPM containing MG (50 μM) and GO (50 μM); cells were removed at 0, 2 and 4 hour time points for 
analysis of motility, CML formation and hyaluronan binding capacity.
Motility assessment. To measure sperm motility for both short-term and long-term glycation experiments,, 5 μl 
sperm from each sample was applied to a cell counting slide in duplicate (CellVision®, Mitrone) and analysed by a 
Computer Assisted Sperm Analyser (CASA – Sperminator®, Procreative). Automated CASA technology allowed 
standardization of measurements, as used elsewhere65,66. Three CASA measurements were recorded for each 
sample and 200 sperm were analyzed per read67. For the long-term glycation experiments - progressive sperm 
motility was assessed at three different time points (24, 48 and 72 hours) as a period of 3 days was chosen as the 
longest period that could be used without any major loss of sperm motility in the control sample47.
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MG toxicity assay. The concentration of MG and GO to use in the glycation experiments was determined using 
a toxicity assay in which sperm (20 × 106/ml) were incubated with 0, 50, 100, 250 and 500 μM MG in SPM for 
48 hours at 34 °C. Due to the limited availability of donor samples, the toxicity assay was carried out on a single 
sample. Vitality was measured using the one-step eosin-nigrosin stain. The stain was prepared as described in 
WHO 5th edition55 Briefly, eosin Y (0.67%) (Sigma, UK) and sodium chloride (NaCl) (0.9%) (Sigma, UK) were 
dissolved in water with gentle heating, before nigrosin (10%) (Sigma, UK) was added, and the solution was boiled, 
then allowed to cool and filtered. Equal volumes of eosin-nigrosin stain and resuspended sperm sample were 
mixed and smeared onto a microscope slide using the feathering technique. Duplicate smears were made for each 
concentration of MG using a fresh aliquot of sperm. Using a light microscope (100 × oil objective), 200 sperm 
were counted on each slide and the average number of live sperm was recorded. The percentage of live sperm were 
calculated as [# live cells/# total cell count] × 100.
The chosen working concentration of MG was 50 µM as the toxicity assay showed only 8% cell death over 
the course of the experiment, in comparison to 28% and 77% cell death at 100 µM and 500 µM MG, respectively.
Measurement of CML. The level of CML on sperm was measured by flow cytometry after both long-term and 
short-term in vitro glycation, as has been demonstrated elsewhere68.
Sperm were removed from glycating solutions after long-term (n = 3) and short-term periods (n = 3) and 
pelleted by centrifugation at 300 g to remove glycation media. Sperm cells were resuspended in paraformalde-
hyde (4%) (Sigma, UK) and incubated at room temperature on a tube rotator (Eppendorf, UK) for 20 minutes. 
Cells were pelleted again and permeabilized by resuspension in 0.1% PBS-tween for 15 minutes. Sperm were then 
blocked in 10% normal goat serum (Vector laboratories, UK) in 1xPBS for 1 hour at room temperature. Cells 
were incubated with a mouse anti-CML primary antibody (1:50) (Abcam, UK, ab125145) for one hour at room 
temperature, followed by a goat anti-mouse Alexa Fluor 488 secondary antibody (1:2000) (Life Technologies, UK) 
for 45 minutes at room temperature in the dark. Cells were then washed once and resuspended in 1xPBS before 
acquisition using a BD FACSCalibur™ (BD Biosciences, UK) and analysed with BD CellQuest™ Pro software 
(BD Biosciences, UK). Cells were gated and debris was excluded in the forward scatter (FSC) and side scatter 
(SSC) plot. Fluorescein isothiocyanate (FITC) fluorescence was detected in the FL-1 channel (488 nm). Each test 
sample was measured in triplicate and 10,000 events were counted each time. A FITC-negative cell population 
was gated using an unstained control sample in the FL-1 channel. Relative CML levels were recorded as the mean 
fluorescence intensity (MFI) of cells.
Measurement of intracellular reactive oxygen species. Spontaneous glycation of biomolecules and later stages 
of the Maillard reaction are associated with the generation of ROS and oxidative stress. Flow cytometric meth-
ods have been established for numerous evaluation parameters in sperm69, including for ROS measurement. 
Intracellular ROS in sperm was measured after long-term glycation incubation (n = 3) with either glucose, MG 
or GO using the CM-H2DCFDA General Oxidative Stress Indicator (Invitrogen, UK). CM-H2DCFDA diffuses 
into cells where it is oxidized to yield a fluorescent adduct, measured in the fluorescein spectrum70,71. The assay 
was carried out as instructed by the manufacturer. Briefly, treated sperm were washed in pre-warmed PBS and 
resuspended in PBS containing the ROS probe. The cells were incubated at 34 °C for 30 minutes. The dye was then 
removed by centrifugation and the cells resuspended in PBS and FITC-positive cell fluorescence was detected by 
flow cytometry under the same conditions as for CML measurement, in the FL-1 channel. A negative control of 
sperm unexposed to the dye was made and a positive control of sperm exposed to H2O2 for 15 minutes prior to 
the assay to induce oxidative damage. These controls were used to gate the fluorescence-negative and -positive 
cells prior to ROS measurement. 10,000 cells were counted in triplicate for each experimental sample (n = 3) and 
relative ROS levels were expressed as MFI values.
Measurement of 8-oxoguanine. The level of oxidative DNA damage in spermatozoa incubated with glycating 
agents over 6 days (n = 3) was determined using the fluorometric OxyDNA Assay Kit (Calbiochem®, EMD 
Millipore, US). The assay is based on a FITC-conjugate that binds to the 8-oxoguanine moiety of oxidized DNA, 
as performed on sperm cells elsewhere69. Sperm cells were centrifuged at 300 g for 7 minutes to pellet the cells and 
remove media. Cells were fixed in 4% PFA and permeabilised with 70% ethanol. Cells were washed with Wash 
Solution (1×) provided with the kit and resuspended in 100 μl FITC-conjugate (1×), before incubation in the 
dark for 1 hour at room temperature. Cells were washed again in Wash Solution (1×), resuspended in 1xPBS and 
analyzed by flow cytometry as for CML. Three flow cytometry measurements were made for each experimental 
sample (n = 3).
Immunocytochemical staining of sperm for AGE and CML. To identify the localization of AGE formation 
on sperm, samples from the long-term incubation experiment (n = 3) were stained for AGEs using a general 
anti-AGE antibody72 (Abcam, UK, ab23722) and specifically for CML using an anti-CML antibody73 (Abcam, 
UK, ab125145). Sperm that had been incubated with SPM, MG and GO were stained for AGEs and CML. 10 μl of 
sperm was placed on one end of a glass microscope slide and smeared across the slide using the feathering tech-
nique and allowed to air dry. Slides were then fixed by submersion in ice-cold methanol (100%) for 15 minutes. 
Once dry, a water-resistant pen (Life technologies, UK) was used to seal the area around the cells. Slides were 
rehydrated in PBS-tween (PBS-T) for 3 minutes before blocking in 10% normal goat serum in PBS-T (0.05%) 
for 1 hour at room temperature. Slides were washed in 3× fresh changes of PBS-T for 1 minute each. Primary 
antibodies were diluted in PBS-T (1:200), added to the slides and incubated in a humidified chamber overnight 
at 4 °C. Negative controls were included in which the primary antibody was omitted. The following day, slides 
were washed in 3× changes of PBS-T and FITC-conjugated goat anti-mouse (1:2000) or goat anti- rabbit (1:2000) 
secondary antibodies were added to the slides staining for CML and AGEs, respectively. Slides were incubated 
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with secondary antibodies for 1 hour at room temperature in a darkened humidified chamber. Slides were washed 
a final 3 times in PBS-T before excess reagent was drained off and sperm nuclei were stained for using Vectashield 
Mounting Medium with DAPI (Vectashield, UK) and finally coverslipped. Fluorescent images were taken using 
an Axio Imager Z1 (Zeiss, HBO 100 mercury lamp) with AxioVision 4 software. Sperm head fluorescence was 
quantified using ImageJ software and the Corrected Total Cell Fluorescence (CCF)74 was obtained using the equa-
tion CCF = initial cell density − (cell area × background intensity).
Sperm hyaluronan binding assay. Functional activity of plasma membrane hyaluronidase in glycated and 
non- glycated sperm was measured using Hyaluronan Binding Assay (HBA) slides75 (Origio, Denmark). At 0, 
2 and 4 hours of incubation with MG, GO or SPM, 8 μl of sperm suspension was removed and placed onto a 
hyaluronan-coated slide and a coverslip was applied. After a 10-minute incubation period in which sperm were 
allowed to bind to hyaluronan, the number of bound motile sperm and the number of unbound motile sperm on 
a 10 × 10 square grid were counted at 40 × magnification. Immotile sperm were not counted. Bound sperm are 
differentiated from unbound sperm by their beating tails with heads that make no progressive movement. Sperm 
motility was also assessed at these stages using the CASA recording grades A (fast progressive motility), B (slow 
progressive motility), C (non-progressive motility) and D (immotile).
Statistical analysis. Statistical analysis was carried out using GraphPad Prism 6 Software (Version 6.01). 
Descriptive statistics were analyzed for each variable, observing means and standard deviation (SD). Ordinary 
one-way ANOVA and Tukey’s multiple comparisons tests were used to identify significant differences across dif-
ferent treatment groups in both short-term and long-term glycation experiments. A repeated measures ANOVA 
and Tukey’s multiple comparisons tests were used to test statistical significance across treatment groups and over 
multiple time points. Statistical significance was established when the above tests returned a p-value < 0.05.
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